Due: June 18, 2025 The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals that leverage emerging neuromodulation technologies to enhance sleep efficiency and performance under sleep-restricted conditions. The Reengineering Enabling Sleep Transitions in Read More
Due: June 13, 2025 NIMH seeks applications for pilot research to adapt, optimize, and test empirically supported behavioral interventions that address common sleep problems in adolescents and young adults with or at risk for a Read More
Due: June 13, 2025 The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer interception and prevention. Read More
Due: June 10, 2025 The purpose of this notice of funding opportunity (NOFO) is to support research studies of two or more vaccine adjuvants (combination adjuvants) in order to understand the mechanisms by which they Read More
Due: June 9, 2025 More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in Read More
Due: June 9, 2025 This Funding Opportunity Announcement (FOA) encourages applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The NIMH seeks teams of researchers working at different levels of Read More
Due: June 6, 2025 The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 applications to support new high-priority biomedical and behavioral research that will provide scientific data to inform the regulation Read More
Due: June 6, 2025 This FOA provides support using the SBIR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated Read More
Anticipated Release Date: Q4FY23 The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) is seeking to establish an integrator for evaluating innovative medical countermeasure (MCM) technologies to meet critical unmet Read More
Due: June 6, 2025 The JPEO-CBRND is interested in late-stage development of host-directed therapeutics or repurposing of United States Food and Drug Administration (FDA) licensed therapeutics that are threat-agnostic with the potential for activity across Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.